Molecular mechanisms of cancer cell progression during liver metastasis formation
肝转移形成过程中癌细胞进展的分子机制
基本信息
- 批准号:11672162
- 负责人:
- 金额:$ 2.3万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The aim of this proposal was to elucidate molecular mechanisms of liver metastasis formation of colon cancer. Our main interest was how host respond during the metastasis process. We have concentrated on the following two research subjects.(1) Adhesion and recognition mechanisms between cancer cells and the liver in the early phase of metastasis : Expression of FH6 monoclonal Ab determinant on colon carcinoma correlates malignancy of the tumor. A colon carcinoma cell line KM 12 expresses FH6 determinant, a unique carbohydrate structure on the following points, containing sialylation anfd fucosylation, not recognized by a part of anti-sialyl lewis X Abs, sensitive to endo-β-glycosidase digestion. To elucidate molecular properties of the carbohydrates we artificially reconsituted FH6 determinants by FUT6 gene transfection into KM 12-LX that lacks expression of FH6 determinant. We showed that hepatocytes recognized the FH6 determinant in the liver. We are now determining the structure of … More 49 kD protein as a candidate of the recognition molecule.(2) Established liver metastasis formation accompanied with reconstitution of host tissues around micrometastasis : We have established a mouse experimental metastasis model that reproduces reconstitution of host tissue around micrometastasis and formation of established metastasis. Based on histochemical observations, we have classified the formation of established metastasis into three steps ; micrometastasis, transient micrometastasis, and established metastasis. In micrometastasis, paticular host cells infilrated into the matastasis region. In transient micrometastasis, many types of host cells infiltrated. Fibroblastic tissue protrusion appeared that accompanied with extracellular matrices and neovascularization and linked neighboring micrometastases. We believe that the process is important as an initial event of fibrosis formation. Established metastasis was rich in fibroblastic stromal tissue. Colon 38 cells separately distributed from host cells in the stromal tissue. We postulate a certain mechanism to separate cancer and stroma in the process of established metasiasis formation. Less
结肠癌的肝脏转移的分子机制,我们集中于以下两个研究对象。 OMA细胞系KM 12表达FH6的决定因素,这是一种独特的碳水化合物结构,在以下几点中,降低了Anfd Fucothisos,而不是由抗siaLyl Lewis X ABS的一部分识别为内部β-糖苷酶的一部分。 Determinants by Fut6 Gene Transfection Into KM 12-Lacks Lacks Expression of FH6 Determinant. We Showed that Hepatocytes Recognant The FH6 Determinant in The Liver. ITABLISHED LIVER METASTASIS FORMATION With Reconstation of Host Tissues Around Micrometastastastastastastastastastastastastastastastastastastasis: we have Established a MOUSE EXPRODUDUCES MODEL MODEL MODEL TISTUE在基于ED的转移的情况下,我们将已建立的转移分为三个步骤;邻近的微晶和纤维形成的初始事件很重要。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sato. K.: "Laminin 5 promotes activation and apoptosis 〜"Exp. Cell Res.. 247. 451-460 (1999)
Sato. K.:“层粘连蛋白 5 促进激活和细胞凋亡 ~”Exp. 247. 451-460 (1999)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Fujita, K.: "Expression of MUS1 mucins in versely correlated"Brut. J. Cancer. 80. 301-308 (1999)
Fujita, K.:“MUS1 粘蛋白的表达呈反向相关”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hirabayashi, K.: "Inhibitation of cancer cell growth by polyinosin 〜"Cancer Res.. 59. 4325-4333 (1999)
Hirabayashi, K.:“聚肌苷对癌细胞生长的抑制 ~”Cancer Res.. 59. 4325-4333 (1999)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kimura, T.: "Epitope mapping of monoclonal antibodies 〜"Mol. Immunol.. (in press). (2000)
Kimura, T.:“单克隆抗体的表位图谱 ~”Mol.Immunol..(出版中)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Higashi, M.: "Expression of MUC1 and MUC2 mucin antigens 〜"Hepatology. 30. 1347-1355 (1999)
Higashi, M.:“MUC1 和 MUC2 粘蛋白抗原的表达 ~”肝病学 30. 1347-1355 (1999)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HIGASHI Nobuaki其他文献
HIGASHI Nobuaki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HIGASHI Nobuaki', 18)}}的其他基金
Heparanase and extracellular matrices regulate cellular trafficking and function of inflammatory immune cells.
乙酰肝素酶和细胞外基质调节细胞运输和炎症免疫细胞的功能。
- 批准号:
22390023 - 财政年份:2010
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regulation of extracellular matrix structure as a biological response to chemical stimuli and irradiation
细胞外基质结构的调节作为对化学刺激和辐射的生物反应
- 批准号:
18390041 - 财政年份:2006
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular analyzes of sensitization phase of contact hypersensitivity
接触性超敏反应致敏期的分子分析
- 批准号:
13672273 - 财政年份:2001
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
驱动结肠癌发生与演进的关键多肽的发现及其作用机制研究
- 批准号:82341016
- 批准年份:2023
- 资助金额:130 万元
- 项目类别:专项基金项目
TWIST1介导的ITGBL1+肿瘤相关成纤维细胞转化加速结肠癌动态演化进程机制及其预防干预研究
- 批准号:82373112
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
CRART16/STAT3/CXCL-8轴调控肿瘤细胞与巨噬细胞串扰在结肠癌肝转移中的作用及靶向药物干预
- 批准号:82372860
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
TRIM21-Hippo-Yap信号转导新机制在结肠癌转移中的作用及其靶向干预研究
- 批准号:82373142
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于T4噬菌体级联酶纳米反应器用于原位结肠癌酶动力-化学动力治疗和乏氧激活的化疗研究
- 批准号:
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:
相似海外基金
The Tumor Antigens Tn and SialylTn in Human Colorectal Carcinoma
人结直肠癌中的肿瘤抗原 Tn 和唾液酸 Tn
- 批准号:
9070397 - 财政年份:2012
- 资助金额:
$ 2.3万 - 项目类别: